Literature DB >> 738333

Cyclophosphamide pretreatment reduces the toxic effect of high dose melphalan on intestinal epithelium in sheep.

J L Millar, T A Phelps, R L Carter, T J McElwain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 738333     DOI： 10.1016/0014-2964(78)90236-0

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  10 in total

1.  Gut protection by cyclophosphamide "priming" in patients receiving high-dose melphalan--effect of drug scheduling.

Authors:  J Mansi; E Ellis; C Viner; J Mundy; T Smith; J Millar; S Milan; M Gore; D Cunningham
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  The effect of pretreatment with thio-TEPA and cytosine arabinoside on megakaryocytopoiesis in rats given a sublethal dose of thio-TEPA.

Authors:  G Tanum; A Sønstevold; A Engeset
Journal:  Blut       Date:  1987-01

Review 3.  Clinical pharmacokinetics of cyclophosphamide.

Authors:  L B Grochow; M Colvin
Journal:  Clin Pharmacokinet       Date:  1979 Sep-Oct       Impact factor: 6.447

4.  Induction of hepatic veno-occlusive disease in dogs.

Authors:  H M Shulman; K Luk; H J Deeg; W B Shuman; R Storb
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

5.  Transition from laboratory to clinic in cancer treatment. Abstracts of symposium papers.

Authors: 
Journal:  Br J Cancer       Date:  1981-05       Impact factor: 7.640

6.  Cyclophosphamide priming reduces intestinal damage in man following high dose melphalan chemotherapy.

Authors:  P J Selby; N Lopes; J Mundy; M Crofts; J L Millar; T J McElwain
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

7.  Verapamil potentiation of melphalan cytotoxicity and cellular uptake in murine fibrosarcoma and bone marrow.

Authors:  B A Robinson; R D Clutterbuck; J L Millar; T J McElwain
Journal:  Br J Cancer       Date:  1985-12       Impact factor: 7.640

8.  Treatment of advanced malignant melanoma with high-dose melphalan and autologous bone marrow transplantation.

Authors:  M A Cornbleet; T J McElwain; P J Kumar; J Filshie; P Selby; R L Carter; D W Hedley; M L Clark; J L Millar
Journal:  Br J Cancer       Date:  1983-09       Impact factor: 7.640

9.  Effects of verapamil and alcohol on blood flow, melphalan uptake and cytotoxicity, in murine fibrosarcomas and human melanoma xenografts.

Authors:  B A Robinson; R D Clutterbuck; J L Millar; T J McElwain
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

10.  Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan.

Authors:  T J McElwain; D W Hedley; G Burton; H M Clink; M Y Gordon; M Jarman; C A Juttner; J L Millar; R A Milsted; G Prentice; I E Smith; D Spence; M Woods
Journal:  Br J Cancer       Date:  1979-07       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.